Eddy Corse
Foot & Ankle Surgery · Lufkin, TXNPI 1265893499
Payments from drug & device makers
What this record shows
Treace Medical Concepts, Inc. accounts for 76.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $847 and has fallen 93.3% since, to $57 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in TX, where the typical reported total is $3,901.
Across 20 payments — averaging $91.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Arthrosurface Incorporated$115
- Organogenesis Inc.$107
- Triad Life Sciences Inc.$55
- Medtronic$50
- Paratek Pharmaceuticals, Inc.$38
- plus $69 from 4 others
What the payments were for
- Travel & lodging$1,04557%
- Food & beverage$77943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 8 | $1,390 |
| Arthrosurface Incorporated | 3 | $115 |
| Organogenesis Inc. | 1 | $107 |
| Triad Life Sciences Inc. | 1 | $55 |
| Medtronic | 1 | $50 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Integra Lifesciences Corporation | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $17 |
| Pylant Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,264
- PuraPly$107
How this compares
$1,824 in reported general payments places this provider in the 30th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 28 | $931 |
| Methylprednisolone | 30 | $241 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $161 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $118 |
| Meloxicam | 16 | $48 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lufkin
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.